REDWOOD CITY, Calif., Aug. 28, 2025 ( GLOBE NEWSWIRE ) -- Codexis, Inc. ( NASDAQ: CDXS ) , a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced the Company will attend the Cantor Global Healthcare Conference, being held ...

REDWOOD CITY, Calif., Aug. 28, 2025 ( GLOBE NEWSWIRE ) -- Codexis, Inc. CDXS, a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced the Company will attend the Cantor Global Healthcare Conference, being held September 3-5, ...

Codexis ( NASDAQ:CDXS ) , a biotechnology company specializing in enzyme engineering for pharmaceutical manufacturing, released its second quarter 2025 results on August 13, 2025. The headline news was an increase in revenue ( GAAP ) to $15.3 million, above analyst expectations of $14.09 million ...

Codexis (CDXS) delivered earnings and revenue surprises of +5.88% and +2.46%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Presentations by leading siRNA CDMOs, Bachem, Nitto Avecia, and ST Pharm, highlight performance and transferability of Codexis double-stranded RNA ligases Management to host conference call today at 8 am Eastern Time to discuss data REDWOOD CITY, Calif., May 22, 2025 ( GLOBE NEWSWIRE ) -- ...